Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 35 (MTND1P35) is a pseudogene associated with the sequence of the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 gene, also known as MT-ND1[4][2]. Unlike the canonical MT-ND1 gene, which encodes a subunit of mitochondrial complex I involved in the electron transport chain and energy production, MTND1P35 is not believed to produce a functional protein and has no established biological activity or role in disease. There are no known drugs, disease associations, or biomarker utility related to this pseudogene, and it is not a recognized therapeutic, diagnostic, or mechanistic molecular target in biomedical research[4][2]. Its nomenclature and gene annotations are listed in gene reference databases, but it does not confer enzyme, receptor, transporter, or regulatory activity. Key clarification: MTND1P35 is distinct from the protein-coding gene MT-ND1 (NADH dehydrogenase 1), which is functionally important in mitochondrial biology and human disease. If your intent was to refer to MT-ND1 itself (not the pseudogene), please clarify for molecular target information relevant to the protein-coding gene[1][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 35 (MTND1P35).